Nuclear Medicine and Biology
Volume 36, Issue 7 , Pages 759-770 , October 2009

177Lu- labeled MOv18 as compared to 131I- or 90Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts

  • Alberto Zacchetti

      Affiliations

    • Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
  • ,
  • Angela Coliva

      Affiliations

    • Department of Imaging and Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
  • ,
  • Elena Luison

      Affiliations

    • Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
  • ,
  • Ettore Seregni

      Affiliations

    • Department of Imaging and Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
  • ,
  • Emilio Bombardieri

      Affiliations

    • Department of Imaging and Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
  • ,
  • Augusto Giussani

      Affiliations

    • Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • ,
  • Mariangela Figini

      Affiliations

    • Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
    • M.F. and S.C. contributed equally to this work.
  • ,
  • Silvana Canevari

      Affiliations

    • Unit of Molecular Therapies, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +390223902567; fax: +390223903073.
    • M.F. and S.C. contributed equally to this work.

Received 31 March 2009 ,Revised 13 May 2009 ,Accepted 15 May 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(09)00129-2

doi: 10.1016/j.nucmedbio.2009.05.004

Nuclear Medicine and Biology
Volume 36, Issue 7 , Pages 759-770 , October 2009